Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

SHA:688163 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,228	1,900	2,163	2,282	-	-
Market Cap Growth	13.92%	-12.16%	-5.22%	-	-	-
Enterprise Value	1,433	1,053	1,312	1,366	-	-
Last Close Price	20.59	17.38	19.33	19.77	-	-
PE Ratio	45.30	42.91	55.79	35.55	-	-
PS Ratio	11.47	9.75	11.38	13.10	-	-
PB Ratio	2.03	1.74	1.99	2.04	-	-
P/TBV Ratio	2.07	1.77	2.04	2.08	-	-
P/FCF Ratio	-	-	521.89	55.06	-	-
P/OCF Ratio	43.59	37.82	65.92	33.61	-	-
EV/Sales Ratio	7.38	5.40	6.90	7.84	-	-
EV/EBITDA Ratio	20.78	16.08	26.52	21.21	-	-
EV/EBIT Ratio	29.72	22.82	39.49	27.09	-	-
EV/FCF Ratio	-304.67	-	316.44	32.96	-	-
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.04	-
Debt / EBITDA Ratio	0.06	0.06	0.26	0.21	0.15	-
Debt / FCF Ratio	-	-	3.13	0.33	0.22	-
Asset Turnover	0.17	0.17	0.17	0.22	0.58	0.55
Inventory Turnover	0.94	1.04	1.00	0.65	0.74	0.68
Quick Ratio	69.92	44.34	35.90	35.06	11.16	8.42
Current Ratio	74.95	46.70	37.98	37.10	14.05	12.03
Return on Equity (ROE)	4.26%	4.06%	3.51%	8.61%	23.03%	20.01%
Return on Assets (ROA)	2.69%	2.56%	1.81%	4.02%	14.34%	14.53%
Return on Capital (ROIC)	2.73%	2.62%	1.86%	4.15%	15.11%	15.58%
Return on Capital Employed (ROCE)	4.40%	4.20%	3.00%	4.40%	21.30%	26.50%
Earnings Yield	2.09%	2.33%	1.79%	2.81%	-	-
FCF Yield	-0.21%	-0.48%	0.19%	1.82%	-	-
Dividend Yield	1.95%	1.84%	1.03%	3.79%	-	-
Payout Ratio	74.35%	78.18%	209.31%	151.70%	-	167.01%
Buyback Yield / Dilution	14.22%	-0.30%	-5.70%	-25.24%	-0.46%	0.23%
Total Shareholder Return	16.13%	1.54%	-4.66%	-21.45%	-0.46%	0.23%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.